Tue.Jan 23, 2024

article thumbnail

Genmab loses appeal in Darzalex royalties arbitration case against Johnson & Johnson

Fierce Pharma

While sales for Johnson & Johnson’s Darzalex continue to boom—as the company reported in its quarterly earnings presentation on Tuesday—the pharma major got more good news about its blockbuster | An appeal arbitrator has rejected Genmab’s claim that it is due additional milestone and royalty payments from Johnson & Johnson for Darzalex. The Danish biotech was hoping to overturn a 2-1 ruling in a second arbitration between the companies over Darzalex royalties.

Sales 284
article thumbnail

Return-to-Office Pushes Can Cause a ‘Riot’

Copyright Clearance Center

A growing number of managers want workers in the office more often, citing the connections, collaborations, and innovations that in-person work can bring.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

J&J, Legend's Carvykti bid for earlier multiple myeloma use will face FDA adcomm

Fierce Pharma

Early evidence showing Carvykti’s potential to prolong patients’ lives in an earlier multiple myeloma setting didn’t save Johnson & Johnson and Legend Biotech’s CAR-T medicine from a public int | Early evidence showing the drug's potential to prolong patients' lives didn't save Johnson & Johnson and Legend Biotech's Carvykti from a public interrogation by the FDA.

FDA 277
article thumbnail

Sanofi Commits $1.7B to Buy an Entire Company, But Wants Just a Single Drug

MedCity News

Sanofi is acquiring Inhibrx to get its hands on a drug candidate in pivotal testing for the protein deficiency alpha-1 antitrypsin deficiency, which leads to lung and liver problems. Inhibrx’s remaining assets will be spun out into a new company.

Leads 122
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth

Fierce Pharma

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth fkansteiner Tue, 01/23/2024 - 11:32

Pharma 277
article thumbnail

Lightfully Behavioral Health Launches Virtual Offering for College Students

MedCity News

Lightfully Behavioral Health unveiled Lightfully U last week. The virtual intensive outpatient program is specifically designed for college students and offers primary and family therapy, access to a psychiatrist, group sessions and other support.

119
119

More Trending

article thumbnail

Will new therapeutic agent replace antibodies for bacterial detection?

European Pharmaceutical Review

As a tool for detecting and identifying bacteria, aptamers are a promising new class of synthetic nucleic acid molecules that can be used to detect and treat of pathogenic bacteria. With the ability to be developed against a whole bacterium, a microbial toxin, or some proteins, for some bacteria, “aptamers against pathogens can not only supplement the deficiency of antibodies but can also enrich the aptamer database to develop efficient analytical regents”, according to a paper published in the

article thumbnail

Lilly trumpets early success with deafness gene therapy

pharmaphorum

Eli Lilly’s gene therapy for otoferlin-related deafness has restored the hearing of the first child enrolled in its ongoing phase 1/2 trial

115
115
article thumbnail

What’s Next for Clinical Decision Support Tools?

MedCity News

Technology evolved over these five decades to respond to the needs of users. Based on my experience and interactions with other leaders in the market, here are three technology trends I expect in 2024.

Marketing 111
article thumbnail

Sanofi snaps up Inhibrx and its rare disease drug for $2.2bn

pharmaphorum

Sanofi agrees $2.2bn deal to buy California biotech Inhibrx and its long-acting therapy for rare disease AATD, which causes life-threatening emphysema.

115
115
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Calls for New Safety Warning for the Class of CAR T Cancer Therapies

MedCity News

Two months after announcing an inquiry into reports of new cancers in patients treated with CAR T-cell therapies, the FDA is directing makers of these therapies to add new safety warnings to product labels describing this risk. Companies have 30 calendar days to comply.

Safety 110
article thumbnail

Digital marketing firm Viseven gets private equity backing

pharmaphorum

Ukraine-based digital pharma marketing specialist Viseven gets private equity investment from Horizon Capital

Marketing 110
article thumbnail

Using Blockchain to Minimize Consumers’ Risk Aversion Toward Generic Drugs

Pharmaceutical Commerce

Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information.

110
110
article thumbnail

NICE backs two AIs for stroke diagnosis in NHS

pharmaphorum

Two artificial intelligence-powered software tools – e-Stroke and RapidAI – have been recommended for use in the NHS to help detect stroke from CT brain scans by NICE. The health technology assessment (HTA) agency said there is some evidence that people admitted to hospital with a suspected had faster or better access to treatment after using the software, although for now it is unclear whether that was a direct consequence of the digital technology.

110
110
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

The Weight Loss Market in 2024: 3 Key Questions We Can No Longer Ignore

MedCity News

In 2024, the weight loss market finds itself at a crossroads, grappling with pivotal questions that will shape the future. The winners will prioritize affordable lifelong care, scalable coaching and support, and a diverse set of solutions that give people second and third chances along their weight loss journeys.

Marketing 108
article thumbnail

Trial raises hopes for simple Alzheimer’s blood test

pharmaphorum

Study finds evidence that an AlZpath immunoassay for phosphorylated tau could deliver an effective blood test for Alzheimer's, paving the way for screening and early treatment

105
105
article thumbnail

Researchers advance blood tests’ ability to detect cancer earlier

PharmaTimes

The advancement could allow earlier detection of cancer in the blood and better treatment

104
104
article thumbnail

Turquoise Health Raises $30M for its Price Transparency Software

MedCity News

Turquoise Health closed a $30 million Series B round, which brings its total funding to date to $55 million. The San Diego-based startup, which has more than 160 customers, sells a platform that makes it easier for hospitals and payers to comply with price transparency regulations.

102
102
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

UK MHRA strengthens regulations on fluoroquinolone antibiotics

Pharmaceutical Technology

The UK MHRA has introduced further restrictions on the usage of fluoroquinolone antibiotics, strengthening the previous regulations.

98
article thumbnail

Is AI’s Copyright World Flat, or Will AI Flatten the Copyright World?

Copyright Clearance Center

AI is global, and copyright laws are national. Thus, some countries will have strict laws on making copies of copyrighted content to “train” an AI system while others will be more relaxed. AI companies will use these jurisdictional differences as leverage to lobby for the relaxation of legal standards.

article thumbnail

Genentech signs nanoparticle deal worth up to $644m with GenEdit

Pharmaceutical Technology

Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therapy delivery in autoimmune diseases.

96
article thumbnail

MIT researchers repurpose cancer compound to treat PKD

PharmaTimes

Autosomal dominant polycystic kidney disease affects more than 12 million people globally

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Why Your Brand Strategy is Essential to Your Healthcare Digital Marketing Success

Healthcare Success

Digital marketing strategies fail when they’re not aligned with your brand. Picture this: a cardiac center that prioritizes personalized care and leading-edge technology. This brand champions expertise, compassion, and patient empowerment. What would happen if the marketing department of this brand launched a social media campaign featuring younger hospital staff doing a trendy dance?

article thumbnail

FDA looks to execute ‘largest reorganization in history’ this year

PharmaVoice

What started as an examination of the Human Foods Program has expanded into an agency-wide overhaul.

Food 69
article thumbnail

Prilenia Announces Plans to Initiate Global Phase III Study of Novel ALS Treatment

Pharmaceutical Commerce

Data from prior Phase II study showed signs of pridopidine slowing disease progression in patients with amyotrophic lateral sclerosis.

article thumbnail

Public Health Matters: A Review of Upcoming Digital Health Technology Products

Pharmacy Times

Public Health Pharmacist discussed wearable technology and AI assisted technology that was displayed at the 2024 Consumer Electronics Show

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Key Considerations in Using Lipid-Based Formulations: Preclinical Toxicology vs Clinical

PharmaTech

Lipid-based formulations can improve the oral bioavailability of some molecules. However, a poor understanding of the technology and complexities limit their use.

52
article thumbnail

Circadian Disruption May Be Significantly Linked to Chronic Kidney Disease

Pharmacy Times

Increased waist circumference and high blood pressure can disrupt circadian rhythm, which can increase risk of progression to poor renal outcomes.

55
article thumbnail

Establishing A Cleanroom that Meets Good Manufacturing Practice (GMP) Guidelines

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

article thumbnail

Fertility Preservation May Not Need to Delay Breast Cancer Treatment

Pharmacy Times

Patients should work with clinicians to discuss controlled ovarian stimulation because there is still limited research.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A